Literature DB >> 6944526

Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma.

C Wagener, R Müller-Wallraf, S Nisson, J Gröner, H Breuer.   

Abstract

In 50 patients with gastrointestinal carcinomas, the following tumor parameters were studied: the concentration and localization of carcinoembryonic antigen (CEA) in tissue, extension, invasion, infiltration, differentiation, and necrosis. CEA concentrations were measured in plasma samples of all patients. In 7 patients with gastric carcinomas, CEA concentrations in tissue were low. Generally, only single cells or cell groups were CEA-positive. Elevated CEA levels in plasma resulted mainly from distant metastases and not from the primary tumor. In 43 colorectal carcinomas, CEA concentrations in tissue varied between 1.5 and 472 microgram/g tissue. They were closely related to the degree of accumulation of CEA-positive necrotic material in the degree of accumulation of CEA-positive necrotic material in the neoplastic glands. In 35 patients with colorectal carcinomas without CEA producing distant metastases, preoperative CEA levels in plasma were normal when tumor necrosis and perineural invasion were absent and CEA concentrations in tissue were low. CEA levels in plasma were regularly elevated when the tumor showed considerable necrosis in the presence of high CEA concentrations in tissue.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6944526

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  16 in total

1.  Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization.

Authors:  P Nollau; F Prall; U Helmchen; C Wagener; M Neumaier
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma.

Authors:  S Koyama; T Ebihara; T Osuga
Journal:  Gastroenterol Jpn       Date:  1987-08

3.  Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents.

Authors:  J Friedman; M Seger; H Levinsky; D Allalouf
Journal:  Experientia       Date:  1987-10-15

4.  Concentration and distribution of tumor associated antigens TAG-72 and CEA in stomach cancer.

Authors:  J K Chung; M C Lee; H K Chung; S M Lim; J J Jang; C S Koh
Journal:  Ann Nucl Med       Date:  1995-02       Impact factor: 2.668

5.  Regulation of carcinoembryonic antigen release from colorectal cancer cells.

Authors:  Abbas Pakdel; Fakhraddin Naghibalhossaini; Pooneh Mokarram; Mansooreh Jaberipour; Ahmad Hosseini
Journal:  Mol Biol Rep       Date:  2011-07-02       Impact factor: 2.316

6.  Contents of tissue CEA and CA19-9 in colonic polyp and colorectal cancer, and their clinical significance.

Authors:  Y Imamura; K Yasutake; Y Yoshimura; M Oya; K Matsushita; M Tokisue; T Sashikata
Journal:  Gastroenterol Jpn       Date:  1990-04

7.  Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients.

Authors:  C Wilmanns; J Grossmann; S Steinhauer; G Manthey; B Weinhold; A Schmitt-Gräff; B U von Specht
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Urinary organ specific neoantigen. A potentially diagnostic test for colorectal cancer.

Authors:  M Tobi; C E Darmon; P Rozen; N Harpaz; A Fink; B Maliakkal; A Halline; S Mobarhan; Z Bentwich
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

Review 9.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Comparative study of CEA staining in gastric and colorectal cancer tissues.

Authors:  O Kojima; T Tanioku; N Kitagawa; Y Uehara; T Majima; E Ikeda; N Iwai; Y Fujita; S Majima
Journal:  Gastroenterol Jpn       Date:  1984-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.